Relative 11C-PiB Delivery As a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2015 Jun 6

PMID 26045309

Citations 45

Authors

Yin J Chen

Bedda L Rosario

Wenzhu Mowrey

Charles M Laymon

Xueling Lu

Oscar L Lopez

William E Klunk

Brian J Lopresti

Chester A Mathis

Julie C Price

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The primary goal of this study was to assess the suitability of (11)C-Pittsburgh compound B ((11)C-PiB) blood-brain barrier delivery (K1) and relative delivery (R1) parameters as surrogate indices of cerebral blood flow (CBF), with a secondary goal of directly examining the extent to which simplified uptake measures of (11)C-PiB retention (amyloid-β load) may be influenced by CBF, in a cohort of controls and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD).

Methods: Nineteen participants (6 controls, 5 AD, 8 MCI) underwent MR imaging, (15)O-water PET, and (11)C-PiB PET in a single session. Fourteen regions of interest (including cerebellar reference region) were defined on MR imaging and applied to dynamic coregistered PET to generate time-activity curves. Multiple analysis approaches provided regional (15)O-water and (11)C-PiB measures of delivery and (11)C-PiB retention that included compartmental modeling distribution volume ratio (DVR), arterial- and reference-based Logan DVR, simplified reference tissue modeling 2 (SRTM2) DVR, and standardized uptake value ratios. Spearman correlation was performed among delivery measures (i.e., (15)O-water K1 and (11)C-PiB K1, relative K1 normalized to cerebellum [Rel-K1-Water and Rel-K1-PiB], and (11)C-PiB SRTM2-R1) and between delivery measures and (11)C-PiB retention, using the Bonferroni method for multiple-comparison correction.

Results: Primary analysis showed positive correlations (ρ ≈0.2-0.5) between (15)O-water K1 and (11)C-PiB K1 that did not survive Bonferroni adjustment. Significant positive correlations were found between Rel-K1-Water and Rel-K1-PiB and between Rel-K1-Water and (11)C-PiB SRTM2-R1 (ρ ≈0.5-0.8, P < 0.0036) across primary cortical regions. Secondary analysis showed few significant correlations between (11)C-PiB retention and relative (11)C-PiB delivery measures (but not (15)O-water delivery measures) in primary cortical areas that arose only after accounting for cerebrospinal fluid dilution.

Conclusion: (11)C-PiB SRTM2-R1 is highly correlated with regional relative CBF, as measured by (15)O-water K1 normalized to cerebellum, and cross-sectional (11)C-PiB retention did not strongly depend on CBF across primary cortical regions. These results provide further support for potential dual-imaging assessments of regional brain status (i.e., amyloid-β load and relative CBF) through dynamic (11)C-PiB imaging.

Citing Articles

[F]MK-6240 Radioligand Delivery Indices as Surrogates of Cerebral Perfusion: Bias and Correlation Against [O]Water.

Fu J, Juttukonda M, Garimella A, Salvatore A, Lois C, Ranasinghe A J Nucl Med. 2025; 66(3):410-417.

PMID: 39947916 PMC: 11876731. DOI: 10.2967/jnumed.124.268701.

A blood-free modeling approach for the quantification of the blood-to-brain tracer exchange in TSPO PET imaging.

Maccioni L, Michelle C, Brusaferri L, Silvestri E, Bertoldo A, Schubert J Front Neurosci. 2024; 18:1395769.

PMID: 39104610 PMC: 11299498. DOI: 10.3389/fnins.2024.1395769.

Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.

Yazdan-Panah A, Bodini B, Soulier T, Veronese M, Bottlaender M, Tonietto M EJNMMI Res. 2024; 14(1):50.

PMID: 38801594 PMC: 11130116. DOI: 10.1186/s13550-024-01107-4.

Dynamic neuroreceptor positron emission tomography in non-anesthetized rats using point source based motion correction: A feasibility study with [C]ABP688.

Kroll T, Miranda A, Drechsel A, Beer S, Lang M, Drzezga A J Cereb Blood Flow Metab. 2024; 44(10):1852-1866.

PMID: 38684219 PMC: 11504418. DOI: 10.1177/0271678X241239133.

Head-to-head comparison of relative cerebral blood flow derived from dynamic [F]florbetapir and [F]flortaucipir PET in subjects with subjective cognitive decline.

Tuncel H, Visser D, Timmers T, Wolters E, Ossenkoppele R, van der Flier W EJNMMI Res. 2023; 13(1):93.

PMID: 37889456 PMC: 10611685. DOI: 10.1186/s13550-023-01041-x.

References

Villemagne V, Pike K, Chetelat G, Ellis K, Mulligan R, Bourgeat P . Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011; 69(1):181-92. PMC: 3045039. DOI: 10.1002/ana.22248. View

Meyer P, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P . Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med. 2011; 52(3):393-400. DOI: 10.2967/jnumed.110.083683. View

Innis R, Cunningham V, Delforge J, Fujita M, Gjedde A, Gunn R . Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007; 27(9):1533-9. DOI: 10.1038/sj.jcbfm.9600493. View

McNamee R, Yee S, Price J, Klunk W, Rosario B, Weissfeld L . Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements. J Nucl Med. 2009; 50(3):348-55. PMC: 2694747. DOI: 10.2967/jnumed.108.057612. View

Pike K, Savage G, Villemagne V, Ng S, Moss S, Maruff P . Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain. 2007; 130(Pt 11):2837-44. DOI: 10.1093/brain/awm238. View

Wolk D, Klunk W . Update on amyloid imaging: from healthy aging to Alzheimer's disease. Curr Neurol Neurosci Rep. 2009; 9(5):345-52. PMC: 2825106. DOI: 10.1007/s11910-009-0051-4. View

Tolboom N, Yaqub M, Boellaard R, Luurtsema G, Windhorst A, Scheltens P . Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009; 36(10):1629-38. PMC: 2758198. DOI: 10.1007/s00259-009-1129-6. View

Mintun M, Larossa G, Sheline Y, Dence C, Lee S, Mach R . [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006; 67(3):446-52. DOI: 10.1212/01.wnl.0000228230.26044.a4. View

Aizenstein H, Nebes R, Saxton J, Price J, Mathis C, Tsopelas N . Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008; 65(11):1509-17. PMC: 2636844. DOI: 10.1001/archneur.65.11.1509. View

10.

Slifstein M . Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM. J Nucl Med. 2008; 49(2):176-8. DOI: 10.2967/jnumed.107.046631. View

11.

Price J, Drevets W, Ruszkiewicz J, Greer P, Villemagne V, Xu L . Sequential H(2)(15)O PET studies in baboons: before and after amphetamine. J Nucl Med. 2002; 43(8):1090-100. View

12.

Ichise M, Cohen R, Carson R . Noninvasive estimation of normalized distribution volume: application to the muscarinic-2 ligand [(18)F]FP-TZTP. J Cereb Blood Flow Metab. 2007; 28(2):420-30. DOI: 10.1038/sj.jcbfm.9600530. View

13.

Ichise M, Liow J, Lu J, Takano A, Model K, Toyama H . Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003; 23(9):1096-112. DOI: 10.1097/01.WCB.0000085441.37552.CA. View

14.

Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A . Unidirectional Influx and Net Accumulation of PIB. Open Neuroimag J. 2009; 2:114-25. PMC: 2695622. DOI: 10.2174/1874440000802010114. View

15.

Logan J, Alexoff D, Fowler J . The use of alternative forms of graphical analysis to balance bias and precision in PET images. J Cereb Blood Flow Metab. 2010; 31(2):535-46. PMC: 3049509. DOI: 10.1038/jcbfm.2010.123. View

16.

Meltzer C, Zubieta J, Links J, Brakeman P, Stumpf M, Frost J . MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab. 1996; 16(4):650-8. DOI: 10.1097/00004647-199607000-00016. View

17.

Wolk D, Price J, Saxton J, Snitz B, James J, Lopez O . Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol. 2009; 65(5):557-68. PMC: 2828870. DOI: 10.1002/ana.21598. View

18.

van Berckel B, Ossenkoppele R, Tolboom N, Yaqub M, Foster-Dingley J, Windhorst A . Longitudinal amyloid imaging using 11C-PiB: methodologic considerations. J Nucl Med. 2013; 54(9):1570-6. DOI: 10.2967/jnumed.112.113654. View

19.

Rosario B, Weissfeld L, Laymon C, Mathis C, Klunk W, Berginc M . Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. Neuroimage. 2011; 55(3):933-41. PMC: 3057323. DOI: 10.1016/j.neuroimage.2010.12.070. View

20.

Meltzer C, Kinahan P, Greer P, Nichols T, Comtat C, Cantwell M . Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med. 2000; 40(12):2053-65. View